Plus Therapeutics (PSTV) Invested Capital (2010 - 2026)
Plus Therapeutics (PSTV) reported Invested Capital of $12.6 million for Q1 2026, up 153.42% year-over-year from $5.0 million in Q1 2025, and up 166.08% quarter-over-quarter from $4.7 million in Q4 2025.
Plus Therapeutics (PSTV) Invested Capital (2010 - 2026) Analysis & Trends
Plus Therapeutics (PSTV) has 17 years of Invested Capital data on file, last reported at $12.6 million in Q1 2026.
- Invested Capital for Q1 2026 came in at $12.6 million, up 153.42% year-over-year; the trailing twelve-month figure through Mar 2026 was $12.6 million (up 153.42% YoY), and the FY2025 annual result was $4.7 million, up 183.9% from the prior year.
- Invested Capital climbed to $12.6 million in Q1 2026 per PSTV's latest filing, from $4.7 million in the prior quarter.
- Over five years, Invested Capital peaked at $16.2 million in Q1 2022 and troughed at -$23.6 million in Q1 2025.
- A 5-year average of $3.6 million and a median of $5.1 million in 2025 frame the typical range for Invested Capital.
- On a YoY basis, Invested Capital climbed as much as 368.54% in 2025 and fell as far as 1795.83% in 2025.
- A 5-year view of Invested Capital shows it stood at $8.1 million in 2022, then slumped by 67.37% to $2.6 million in 2023, then plunged by 315.26% to -$5.7 million in 2024, then soared by 183.9% to $4.7 million in 2025, then soared by 166.08% to $12.6 million in 2026.
- Business Quant data shows PSTV's Invested Capital at $12.6 million in Q1 2026, $4.7 million in Q4 2025, and $5.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | 7.14 Bn |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | 795.79 Mn |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 595,226.00 |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 14.38 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 19.36 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | 502.95 Mn |
| 10 | Plus Therapeutics | 33.89 Mn | 18.78 Mn | - | 12.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.63 Mn |
| Dec 31, 2025 | 4.75 Mn |
| Sep 30, 2025 | 5.05 Mn |
| Jun 30, 2025 | 3.03 Mn |
| Mar 31, 2025 | -23.64 Mn |
| Dec 31, 2024 | -5.66 Mn |
| Sep 30, 2024 | -1.88 Mn |
| Jun 30, 2024 | -4.33 Mn |
| Mar 31, 2024 | -1.25 Mn |
| Dec 31, 2023 | 2.63 Mn |
| Sep 30, 2023 | 6.97 Mn |
| Jun 30, 2023 | 7.37 Mn |
| Mar 31, 2023 | 7.73 Mn |
| Dec 31, 2022 | 8.05 Mn |
| Sep 30, 2022 | 13.01 Mn |
| Jun 30, 2022 | 11.29 Mn |
| Mar 31, 2022 | 16.25 Mn |
| Dec 31, 2021 | 12.44 Mn |
| Sep 30, 2021 | 21.51 Mn |
| Jun 30, 2021 | 18.56 Mn |